BIONET Corp.

NT$45.90As of Sun 8 Nov 2026, 12:00 UTC
TPEx:1784Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 5.60%
Div yield 1.90%
ROE 0.37%
Diagnostics & Research
Beta (5Y) 0.62
PE TTM 40.34
TSR TTM (55.00%)
Mkt cap NT$2.287B
ROIC (0.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$51
11.01%
(77.19%)
Buy 6|3|1|2|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.91
0.91
1.00
1.08
24.44%
20.96%
23.60%
29.64%
RevenueNT$M
105.8
110.4
112.7
113.9
7.41%
13.06%
10.71%
12.95%
Peers (US$69.08M)
Cap (US$)
PE
28.26M
52.31x
Capital
TTM
5Y
10Y
Leveragex
1.656
(0.037)
(0.027)
EBIT/Intx
0.044
0.377
0.282
Own earn%
(80.85)
124.84
128.80
Sh yield%
46.20
24.24
25.53
Owners
Insiders/Inst%
11.84
25.37
Short interest%
1.56
SBC / revenue%
5.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
1–9
$1 testx
0.0
Incr. ROIC%
16